皮肤科医生对生物类似药的看法
Journal of drugs in dermatology : JDD
|April 2, 2024
概括
皮肤科医生表示不愿意开处方生物类似药,许多人提到安全性和有效性问题. 需要采取教育举措,以改善在皮肤病学中采用这些安全有效的生物制剂.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 生物类似药是FDA批准的生物制剂,与参考生物制剂没有临床差异.
- 在皮肤病学中,生物类药物已被批准用于牛皮和炎治疗.
- 皮肤科医生与其他专家相比,犹不决地开处方生物类似药.
研究的目的:
- 描述当前皮肤科医生对生物类似药采用的看法.
- 识别皮肤病学中生物类似药物处方的障碍.
主要方法:
- 一个27个问题的调查被发送给皮肤科医生.
- 数据是在2022年9月至10月期间收集的.
主要成果:
- 20%的皮肤科医生不会为FDA批准的指示处方生物类药物.
- 主要障碍包括对安全性和有效性的担忧 (61%) 和可互换性法律 (24%) 的担忧.
- 只有35%的人认为他们了解生物类似物互换性.
结论:
- 生物类药物对经批准的皮肤病有安全性和有效性,可以降低患者的成本.
- 皮肤科医生不熟悉可能导致患者不被提供生物类似疗法.
- 建议对生物类似药物的安全性,有效性和可互换性进行教育.
相关概念视频
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K


